prodermic | clinical documentation

565 PROCEDURE GUIDE

Gentle Melasma Protocol — Step-by-Step Clinical Application Guide for Practitioners

Melasmonil Peel · 4-Agent Combo Peel Self-Neutralizing · 2–3 Hr Contact Fitzpatrick II–VI

Product Overview

prodermic 565 Melasmonil Peel

prodermic® 565

Gentle Melasma Protocol · Melasmonil Peel

Type4-Agent Combo Peel
Total Active4-Agent Combo
Size30ml jar
Yield~24 sessions per jar
FitzpatrickII–VI
Peel DepthVery Superficial

Active Composition

Glycolic
Lactic
Citric
Kojic

Mechanism of Action

AgentMechanism
Glycolic AcidGentle surface exfoliation at low concentration tolerable for reactive skin. Promotes cell turnover and enhances penetration of other actives.
Lactic AcidHydrating exfoliation that strengthens the skin barrier and supports ceramide synthesis. Ideal for sensitive and darker skin types.
Citric AcidAntioxidant buffer and pH adjuster that prevents irritation. Provides additional brightening action through melanin pathway inhibition.
Kojic AcidSteady tyrosinase inhibition that blocks pigment production with minimal irritation. Key depigmenting agent targeting melasma at the source.

Clinical Indications

Sensitive Melasma
Sensitive Melasma
Rosacea-prone
Rosacea-prone
First-time Peels
First-time Peels

Patient Selection & Pre-Procedure

Ideal Patient Profile

Contraindications

DO NOT TREAT IF

Pre-Procedure Patient Preparation

  1. Skin Assessment: Evaluate skin type, melasma severity, sensitivity level, rosacea presence, and prior peel history to determine suitability.
  2. Sun Exposure: Advise patient to avoid direct sun exposure for at least 1 week prior. Melasma patients must already be on strict SPF 50+ routine.
  3. Discontinue: Stop topical retinoids 72 hours before. Stop AHAs/BHAs 48 hours before.
  4. Informed Consent: Discuss expected outcomes, downtime (1–3 days of mild flaking), self-neutralizing nature (patient washes off at home after 2–3 hours), and possible side effects.
  5. Photography: Take standardized baseline photographs under consistent lighting. Document melasma patches with close-up images.

Step-by-Step Procedure

KEY: SELF-NEUTRALIZING GENTLE FORMULA

prodermic 565 is a self-neutralizing gentle peel specifically designed for sensitive skin. It is applied in-clinic and the patient leaves with the peel on. The peel self-neutralizes over 2–3 hours. The patient washes it off at home after the contact period. The gentle concentration means significantly less irritation risk compared to aggressive peels, making it ideal for rosacea-prone and reactive skin types.

01
Cleanse & Degrease
Cleanse the treatment area with a gentle, non-residue cleanser. Remove all makeup, sunscreen, and surface impurities. Then degrease the skin using a pre-peel degreasing solution (e.g., glycolic prep, acetone, or alcohol prep) applied with gauze or cotton pads. Wipe across the entire treatment area to ensure uniform acid penetration.
Degreasing contact: 1–2 minutes. Wipe clean. Allow skin to dry for 30 seconds before proceeding.
02
Patch Test (First Session Only)
For the patient's first session, perform a mandatory patch test. Apply a small amount of prodermic 565 to the post-auricular area (behind the ear). Wait 10 minutes and observe for signs of excessive irritation, burning, or allergic reaction.
If the patient shows no adverse reaction after 10 minutes, proceed with full application. If irritation occurs, do NOT proceed — remove product immediately. Given the gentle formulation, adverse patch test reactions are uncommon but must still be checked.
03
Apply prodermic 565
Using a fan brush, apply a thin, even layer of prodermic 565 across the entire treatment area. This is a gentle peel specifically designed for sensitive skin — the lower concentration ensures tolerability even for reactive and rosacea-prone patients. Work systematically:
  1. Forehead: Apply in horizontal strokes from center outward
  2. Cheeks: Apply from the nose outward toward the ears — focus on melasma patches
  3. Nose: Light application across the bridge and sides
  4. Chin: Apply in upward strokes
  5. Upper lip: Light, thin application (sensitive area, common melasma site)
Use approximately 1–1.25ml of product per full-face application. Avoid the periorbital area (around eyes), lips, and nostrils. Apply slightly more product over visible melasma patches for targeted treatment.
04
Observe Initial Response (3–5 Minutes)
After application, observe the patient in-clinic for 3–5 minutes to ensure no adverse immediate reactions. Mild warmth is expected. Sensitivity should be significantly less than with aggressive peels due to the gentle formulation.
  • Mild warmth: Normal — this is the expected initial response for a gentle peel
  • Slight tingling: Normal and should subside quickly as the peel begins self-neutralizing
  • Moderate stinging or burning: Unusual for this gentle formulation — monitor closely and consider removal if it persists
Once you confirm tolerance, the patient is ready for discharge with at-home instructions. Observation time is shorter than aggressive peels because 565 is formulated for sensitive skin.
05
Discharge with At-Home Instructions
Once the initial observation is complete and the patient shows no adverse reaction:
  1. Leave the peel on: The patient leaves with the peel on their face
  2. Contact time: Instruct the patient to leave it on for 2–3 hours (as per progressive protocol)
  3. Wash off at home: After the prescribed contact time, rinse thoroughly with lukewarm water until all residue is removed
  4. Apply a soothing recovery moisturizer immediately after washing
  5. No other actives or makeup for the rest of the day
Provide the patient with written or WhatsApp post-care instructions before they leave. Schedule next session in 10–14 days.
06
Post-Peel Soothing (At Home)
After washing off the peel at home:
  1. Pat skin dry gently — do not rub
  2. Apply a thick, bland recovery moisturizer or balm generously
  3. Do not apply any actives, serums, or makeup until the next morning
  4. Sleep on a clean pillowcase
Mild redness post-wash is normal and should subside within a few hours. Redness will be less intense than with aggressive peels — reassure the patient that this gentle formulation is designed to minimise post-procedure irritation.

Early Removal & Adverse Reactions

INSTRUCT PATIENT TO WASH OFF IMMEDIATELY IF

Emergency Removal Steps (At Home)

  1. Rinse the treatment area thoroughly with cold water until all product is removed
  2. Continue rinsing until all tingling/burning completely stops
  3. Apply a thick, bland moisturizer (no actives)
  4. Apply a cold compress for comfort if needed
  5. Contact the clinic immediately to report the reaction
  6. Document the reaction — reduce contact time for the next session

PATIENT COMMUNICATION

Post-Procedure Care Instructions

Provide these instructions to the patient (verbal + printed/WhatsApp):

Day 0 (Day of Procedure)

Day 1 (Tightness Phase)

Days 1–2 (Mild Flaking Phase)

Day 3+ (Recovery)

Days 5–14 (Between Sessions)

Expected Peeling Timeline

Day 0
Application
Applied in-clinic, wash off at home after 2–3 hrs
Day 1
Mild Tightness
Skin feels slightly tight
Day 1–2
Mild Flaking
Very mild flaking — may not peel visibly
Day 3
Smoother Skin
Skin feels smoother, brighter
Day 10–14
Next Session
Repeat protocol

Treatment Program

ParameterRecommendation
Total Sessions6–8 sessions (assess at session 3)
Session Interval10–14 days between sessions
Contact Time2–3 hours (self-neutralizing, washed off at home)
Downtime1–3 days mild flaking per session
Full Program Duration2–3 months (6–8 sessions at 10–14 day intervals)
Product per SessionApproximately 1–1.25ml (full face)
Yield per Jar~24 full-face sessions from one 30ml jar
Maintenance1 session every 4–6 weeks after initial program, or as needed

Progressive Protocol Guide

Adjust contact time progressively across sessions based on patient tolerance. Start conservatively — especially important for sensitive skin:

SessionContact TimeNotes
Session 11.5 hoursConservative first exposure for sensitive skin. Assess skin response and tolerance the next day.
Session 22 hoursIncrease if Session 1 was well tolerated with no adverse effects.
Session 32–2.5 hoursContinue increasing if good tolerance. Assess clinical results so far — evaluate melasma response.
Session 4+2.5–3 hoursMaximum contact time. Do not exceed 3 hours.

Expected Outcomes

Set realistic expectations: The 565 is a gentle, conservative protocol. Results are gradual and cumulative — melasma responds best to consistent, low-aggression treatment over multiple sessions. Patients who tolerate 565 well may be escalated to prodermic 580 for more intensive depigmentation.

Full Ingredient List

Glycolic Acid, Lactic Acid, Citric Acid, Kojic Acid, Liquorice Extract, Tea Tree Extract

Clinical Results

Real patient outcomes with prodermic 565. Tap any image to enlarge.

prodermic 565 melasma result
tap to enlarge
prodermic 565 melasmonil peel result
tap to enlarge
prodermic 565 peel result
tap to enlarge
prodermic 565 melasmonil result
tap to enlarge

prodermic

for medical professionals only
This document is intended for trained dermatologists and aestheticians only. Do not distribute to patients. For ordering and support: wa.me/918208708438